rs141952919

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198999.3(SLC26A5):​c.137T>C​(p.Leu46Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00424 in 1,614,138 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0044 ( 26 hom. )

Consequence

SLC26A5
NM_198999.3 missense

Scores

7
8
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 6.17

Publications

10 publications found
Variant links:
Genes affected
SLC26A5 (HGNC:9359): (solute carrier family 26 member 5) This gene encodes a member of the SLC26A/SulP transporter family. The protein functions as a molecular motor in motile outer hair cells (OHCs) of the cochlea, inducing changes in cell length that act to amplify sound levels. The transmembrane protein is an incomplete anion transporter, and does not allow anions to cross the cell membrane but instead undergoes a conformational change in response to changes in intracellular Cl- levels that results in a change in cell length. The protein functions at microsecond rates, which is several orders of magnitude faster than conventional molecular motor proteins. Mutations in this gene are potential candidates for causing neurosensory deafness. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]
SLC26A5 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 61
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028838605).
BP6
Variant 7-103421378-A-G is Benign according to our data. Variant chr7-103421378-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 165272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00265 (403/152334) while in subpopulation NFE AF = 0.00476 (324/68024). AF 95% confidence interval is 0.00434. There are 3 homozygotes in GnomAd4. There are 183 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC26A5NM_198999.3 linkc.137T>C p.Leu46Pro missense_variant Exon 3 of 20 ENST00000306312.8 NP_945350.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC26A5ENST00000306312.8 linkc.137T>C p.Leu46Pro missense_variant Exon 3 of 20 1 NM_198999.3 ENSP00000304783.3
SLC26A5ENST00000393727.5 linkc.137T>C p.Leu46Pro missense_variant Exon 1 of 18 1 ENSP00000377328.1
SLC26A5ENST00000393723.2 linkc.137T>C p.Leu46Pro missense_variant Exon 1 of 17 1 ENSP00000377324.1

Frequencies

GnomAD3 genomes
AF:
0.00265
AC:
403
AN:
152216
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000844
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00476
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00312
AC:
785
AN:
251314
AF XY:
0.00319
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00377
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000832
Gnomad NFE exome
AF:
0.00502
Gnomad OTH exome
AF:
0.00408
GnomAD4 exome
AF:
0.00440
AC:
6436
AN:
1461804
Hom.:
26
Cov.:
32
AF XY:
0.00437
AC XY:
3179
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33480
American (AMR)
AF:
0.000984
AC:
44
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00398
AC:
104
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00255
AC:
220
AN:
86252
European-Finnish (FIN)
AF:
0.00144
AC:
77
AN:
53414
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00519
AC:
5776
AN:
1111958
Other (OTH)
AF:
0.00318
AC:
192
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
344
688
1032
1376
1720
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00265
AC:
403
AN:
152334
Hom.:
3
Cov.:
32
AF XY:
0.00246
AC XY:
183
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41590
American (AMR)
AF:
0.000785
AC:
12
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4832
European-Finnish (FIN)
AF:
0.000848
AC:
9
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00476
AC:
324
AN:
68024
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00407
Hom.:
9
Bravo
AF:
0.00255
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.00325
AC:
395
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00524
EpiControl
AF:
0.00486

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 14, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC26A5: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Feb 22, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu46Pro in Exon 03 of SLC26A5: This variant is not expected to have clinical si gnificance because it has been identified in 0.5% (34/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs141952919). -

SLC26A5-related disorder Benign:1
Sep 17, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Autosomal recessive nonsyndromic hearing loss 61 Benign:1
Sep 25, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.91
BayesDel_addAF
Benign
-0.035
T
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
.;.;.;.;D;.;T;.;T;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.60
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
D;D;D;.;D;D;D;D;.;D
M_CAP
Pathogenic
0.47
D
MetaRNN
Benign
0.029
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.68
D
MutationAssessor
Benign
1.7
L;L;L;L;L;L;.;.;.;L
PhyloP100
6.2
PrimateAI
Uncertain
0.71
T
PROVEAN
Pathogenic
-4.8
D;D;D;D;D;D;.;D;D;D
REVEL
Pathogenic
0.80
Sift
Uncertain
0.0040
D;D;D;D;D;D;.;D;D;D
Sift4G
Uncertain
0.0070
D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
D;D;D;.;P;.;.;.;.;.
Vest4
0.65
MVP
0.96
MPC
0.69
ClinPred
0.030
T
GERP RS
5.4
PromoterAI
0.041
Neutral
Varity_R
0.87
gMVP
0.91
Mutation Taster
=287/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141952919; hg19: chr7-103061825; API